Sunbelt Securities, Inc.
Broker-DealerPosition in VTVT — vTv Therapeutics Inc.
CIK 1632932
HOUSTON, TX
Position in VTVT
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$594
-$5 QoQ
Shares Held
15
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTVT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Sunbelt Securities, Inc. holds $1,185,078 across 103 Biotechnology names. VTVT ranks #37 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,022 | $456,363 | |
| 2 | CRSP |
CRISPR Therapeutics AG
|
7,843 | $373,091 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
1,014 | $76,141 | |
| 4 | MDXG |
Mimedx Group, Inc.
|
10,596 | $41,854 | |
| 5 | AUPH |
Aurinia Pharmaceuticals Inc.
|
2,453 | $36,353 | |
| 6 | ARGX |
Argenx SE
|
49 | $35,782 | |
| 7 | ALT |
Altimmune, Inc.
|
10,870 | $33,479 | |
| 8 | RPRX |
Royalty Pharma plc
|
280 | $13,431 |
All Filings in VTVT
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $594 | 15 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $599 | 15 | Shares | Sole | 2026-02-20 | |
| 2025-09-30 | $350 | 15 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $225 | 15 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $259 | 15 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $207 | 15 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $203 | 15 | Shares | Sole | 2024-11-18 | |
| 2024-06-30 | $264 | 15 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $352 | 15 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $172 | 15 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $286 | 600 | Shares | Sole | 2023-12-11 | |
| No filing history on record for this holder in this stock. | ||||||